Cristina Lo Giudice

Cristina Lo Giudice

Auto-generated profile, based on publicly available information

Cristina Lo Giudice

Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2020 in Chemical Reviews
Verified
Journal Article
Closed access
DMDaniel J. Müller
Daniel J. Müller
ADAndra C. Dumitru
Andra C. Dumitru
CGCristina Lo Giudice
Cristina Lo Giudice
HGHermann E. Gaub
Hermann E. Gaub
PHPeter Hinterdorfer
Peter Hinterdorfer
DADavid Alsteens
David Alsteens

31 January 2017 in ACS Nano
Verified
Journal Article
Open access
SLSandra Lara
Sandra Lara
FAFatima Alnasser
Fatima Alnasser
Ester PoloEster Polo
Ester Polo
DGDavid Garry
David Garry
MGMaria Cristina Lo Giudice
Maria Cristina Lo Giudice
KDKenneth A. Dawson
Kenneth A. Dawson
Biomolecules adsorbed on nanoparticles are known to confer a biological identity to nanoparticles, mediating the interactions with cells and biological barriers. However, how these molecules are presented on the particle surface in biological milieu remains unclear. The central aim of this study is to identify key protein recognition motifs and link them to specific cell-receptor interactions. Here, we employed an immuno-mapping technique to quantify epitope presentations of two major proteins in the serum corona, low-density lipoprotein and immunoglobulin G. Combining with a purpose-built receptor expression system, we show that both proteins present functional motifs to allow simultaneous recognition by low-density lipoprotein receptor and Fc-gamma receptor I of the corona. Our results suggest that the “labeling” of nanoparticles by biomolecular adsorption processes allows for multiple pathways in biological processes in which they may be “mistaken” for endogenous objects, such as lipoproteins, and exogenous ones, such as viral infections.

15 November 2016 in Nature Communications
Verified
Journal Article
Open access
MGMaria Cristina Lo Giudice
Maria Cristina Lo Giudice
LHLuciana M. Herda
Luciana M. Herda
Ester PoloEster Polo
Ester Polo
KDKenneth A. Dawson
Kenneth A. Dawson
Nanoparticles interacting with, or derived from, living organisms are almost invariably coated in a variety of biomolecules presented in complex biological milieu, which produce a bio-interface or ‘biomolecular corona’ conferring a biological identity to the particle. Biomolecules at the surface of the nanoparticle–biomolecule complex present molecular fragments that may be recognized by receptors of cells or biological barriers, potentially engaging with different biological pathways. Here we demonstrate that using intense fluorescent reporter binders, in this case antibodies bound to quantum dots, we can map out the availability of such recognition fragments, allowing for a rapid and meaningful biological characterization. The application in microfluidic flow, in small detection volumes, with appropriate thresholding of the detection allows the study of even complex nanoparticles in realistic biological milieu, with the emerging prospect of making direct connection to conditions of cell level and in vivo experiments.

16 August 2019 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
CPCristina Pavan
Cristina Pavan
Massimo Delle PianeMassimo Delle Piane
Massimo Delle Piane
MGMaria Gullo
Maria Gullo
FFFrancesca Filippi
Francesca Filippi
BFBice Fubini
Bice Fubini
Francesco TurciFrancesco Turci
Francesco Turci
Silica continues to represent an intriguing topic of fundamental and applied research across various scientific fields, from geology to physics, chemistry, cell biology, and particle toxicology. The pathogenic activity of silica is variable, depending on the physico-chemical features of the particles. In the last 50 years, crystallinity and capacity to generate free radicals have been recognized as relevant features for silica toxicity. The ‘surface’ also plays an important role in silica toxicity, but this term has often been used in a very general way, without defining which properties of the surface are actually driving toxicity. How the chemical features (e.g., silanols and siloxanes) and configuration of the silica surface can trigger toxic responses remains incompletely understood. Recent developments in surface chemistry, cell biology and toxicology provide new avenues to improve our understanding of the molecular mechanisms of the adverse responses to silica particles. New physico-chemical methods can finely characterize and quantify silanols at the surface of silica particles. Advanced computational modelling and atomic force microscopy offer unique opportunities to explore the intimate interactions between silica surface and membrane models or cells. In recent years, interdisciplinary research, using these tools, has built increasing evidence that surface silanols are critical determinants of the interaction between silica particles and biomolecules, membranes, cell systems, or animal models. It also has become clear that silanol configuration, and eventually biological responses, can be affected by impurities within the crystal structure, or coatings covering the particle surface. The discovery of new molecular targets of crystalline as well as amorphous silica particles in the immune system and in epithelial lung cells represents new possible toxicity pathways. Cellular recognition systems that detect specific features of the surface of silica particles have been identified. Interdisciplinary research bridging surface chemistry to toxicology is progressively solving the puzzling issue of the variable toxicity of silica. Further interdisciplinary research is ongoing to elucidate the intimate mechanisms of silica pathogenicity, to possibly mitigate or reduce surface reactivity.

29 December 2016 in Journal of the American Chemical Society
Verified
Journal Article
Open access
LHLuciana M. Herda
Luciana M. Herda
DHDelyan Hristov
Delyan Hristov
MGMaria Cristina Lo Giudice
Maria Cristina Lo Giudice
Ester PoloEster Polo
Ester Polo
KDKenneth A. Dawson
Kenneth A. Dawson
Characterizing the orientation of covalently conjugated proteins on nanoparticles, produced for in vitro and in vivo targeting, though an important feature of such a system, has proved challenging. Although extensive physicochemical characterization of targeting nanoparticles can be addressed in detail, relevant biological characterization of the nanointerface is crucial in order to select suitable nanomaterials for further in vitro or in vivo experiments. In this work, we adopt a methodology using antibody fragments (Fab) conjugated to gold nanoparticles (immunogold) to map the available epitopes on a transferrin grafted silica particle (SiO2–PEG8–Tf) as a proxy methodology to predict nanoparticle biological function, and therefore cellular receptor engagement. Data from the adopted method suggest that, on average, only ∼3.5% of proteins grafted on the SiO2–PEG8–Tf nanoparticle surface have a favorable orientation for recognition by the cellular receptor.

20 April 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
VCV. Castagnola
V. Castagnola
WZW. Zhao
W. Zhao
LBL. Boselli
L. Boselli
MGM. C. Lo Giudice
M. C. Lo Giudice
Fabian MederFabian Meder
Fabian Meder
KDK. A. Dawson
K. A. Dawson
The systematic study of nanoparticle–biological interactions requires particles to be reproducibly dispersed in relevant fluids along with further development in the identification of biologically relevant structural details at the materials–biology interface. Here, we develop a biocompatible long-term colloidally stable water dispersion of few-layered graphene nanoflakes in the biological exposure medium in which it will be studied. We also report the study of the orientation and functionality of key proteins of interest in the biolayer (corona) that are believed to mediate most of the early biological interactions. The evidence accumulated shows that graphene nanoflakes are rich in effective apolipoprotein A-I presentation, and we are able to map specific functional epitopes located in the C-terminal portion that are known to mediate the binding of high-density lipoprotein to binding sites in receptors that are abundant in the liver. This could suggest a way of connecting the materials' properties to the biological outcomes.